PeptideStack
5.2kquestions
20kanswers
220users

What does 98.4% purity on a C18 column actually tell me about an ecnoglutide vial?

Asked 8 Apr 2025Modified 12 months agoViewed 21k times
7

What I am working with: 98.4% · a C18 column · ecnoglutide.

I would like help reading this properly rather than being told what conclusion to reach.

I have the full report including the method section, so I can quote specifics if that helps.

What would I need in addition before this supported a decision?

hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
shareeditfollowflag
PH
askedper_haugen18k188 Apr 2025

5 Answers

Accepted answer first, then by votes
49

Accepted answer

Stated carefully, the most important parameter is the one that is almost never specified: the gradient slope during the region where your main peak elutes.

Trifluoroacetic acid at 0.1 per cent is the standard ion-pairing agent because it suppresses tailing by neutralising the basic residues, but it also suppresses mass spectrometry signal.

Mass shifts and what they usually mean

Δ mass (Da)Most likely causeDistinguishing feature
+1Deamidation (Asn or Gln)New peak, slightly earlier retention
−17Loss of ammoniaOften with deamidation
−18Dehydration / succinimidepH-dependent, reversible
+16Oxidation (Met, Trp)Earlier retention, light-related
−128Missing Gln or LysDeletion sequence from synthesis
0Isomer: racemisation or scramblingSame mass, shifted retention

Mobile phase pH at the point where you inject must match the mobile phase pH at the start of the gradient, or the sample will not be focused at the column head.

Inter-laboratory studies using identical methods on identical material show precision well within half a per cent when the method is locked down, pointing to method variability as the primary source of disagreement.

The limitation is that co-elution is invisible — if two species happen to have the same retention time, they will report as a single peak at their combined area.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.

edited 7 Aug 2025 by micron22 — added the method parameters

shareimprove this answerflag
MI
answered · acceptedmicron2236k13818 Jul 2025
Two of us worked through this independently and arrived here, so it is at least reproducible. – tobias_maartens 7 months ago
8Worth adding that the method section is where the answer usually is. – Dr_Fatima_Belkacem 5 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
52

The method is the measurement in reverse-phase chromatography, more so than in almost any other analytical domain, and two methods that look identical can easily produce different results.

Proline-rich sequences are particularly problematic because the isomerisation kinetics are in the same timescale as the separation, leading to split or broadened peaks at low temperature.

Wider-pore phases — 300 Angstrom rather than 100 Angstrom — have faster mass transfer and narrower peaks for peptides above three kilodaltons, which is almost every peptide you will see.

The caveat is that HPLC is a purity technique and says almost nothing about whether the main peak is actually your target compound — that is why identity confirmation from mass spectrometry or peptide mapping matters.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

shareimprove this answerflag
AM
answeredaine_mulcahy35k3826 Jun 2025
34

Start by understanding what the detector is measuring and what that means about how the molecule needs to be prepared and handled before injection.

Sample preparation is almost always under-appreciated — a reconstituted peptide in strong solvent will distort its own peak on the gradient.

It helps to be literal here: acetonitrile is the organic modifier of choice because it has a good UV cutoff, a reasonable viscosity and a refractive index that minimises baseline noise.

The selectivity of a reverse-phase separation depends on the hydrophobicity of the side-chain profile, which is why two peptides can co-elute even if they differ by a residue.

Ask for the chromatogram and the system suitability data, not just the number.

shareimprove this answerflag
SB
answereds_bhattacharya42k387 Jul 2025
22

The chemistry of peptides at low pH and high organic-solvent concentration is not something most users have intuition for, which is why published methods exist.

Temperature affects both the viscosity of the mobile phase and the dynamics of molecular interactions, and a method developed at 25 degrees and run at 40 degrees will not behave identically.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.

shareimprove this answerflag
DA
answeredDr_Rosalind_Achebe90k15830 Jul 2025
The timing signature is the useful part. Everything else is confounded. – Dr_Malik_Osei 4 months ago
add a comment
16

Coupling the chromatography to mass spectrometry adds identity information but trades chromatographic quality for ionisation efficiency.

Formic acid is the compromise when you need the mass spectrometer on the same run, but the peak shape penalty is real and easily a tenth of a per cent on purity.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

edited 24 Apr 2025 by tobias_maartens — added the citation requested in comments

shareimprove this answerflag
TM
answeredtobias_maartens94k25812 Apr 2025
6This is the answer I was looking for three months ago. – fib4_reader 5 months ago
5The arithmetic checks out. I ran the same numbers and got the same result. – Dr_Malik_Osei 3 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.